US BANCORP \DE\ - AILERON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AILERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$5,000
-28.6%
25,0000.0%0.00%
Q2 2022$7,000
-46.2%
25,0000.0%0.00%
Q1 2022$13,000
-7.1%
25,0000.0%0.00%
Q4 2021$14,000
-46.2%
25,0000.0%0.00%
Q3 2021$26,000
-16.1%
25,0000.0%0.00%
Q2 2021$31,000
-13.9%
25,0000.0%0.00%
Q1 2021$36,000
+38.5%
25,0000.0%0.00%
Q4 2020$26,000
-18.8%
25,0000.0%0.00%
Q3 2020$32,000
+6.7%
25,0000.0%0.00%
Q2 2020$30,000
+275.0%
25,0000.0%0.00%
Q1 2020$8,000
-42.9%
25,0000.0%0.00%
Q4 2019$14,000
-17.6%
25,0000.0%0.00%
Q3 2019$17,000
-5.6%
25,0000.0%0.00%
Q2 2019$18,00025,0000.00%
Other shareholders
AILERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 16,609,449$9,349,0009.51%
KCK LTD. 646,817$362,0000.26%
Ikarian Capital, LLC 2,763,583$1,556,0000.23%
BVF INC/IL 5,265,555$2,964,0000.11%
PVG ASSET MANAGEMENT CORP 50,300$28,313,0000.10%
MORGAN JESS S & CO INC 100,000$56,0000.03%
Game Plan Financial Advisors, LLC 88,000$50,0000.03%
Keebeck Wealth Management, LLC 70,000$39,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 278,743$157,0000.00%
RIDGECREST WEALTH PARTNERS, LLC 10,000$6,0000.00%
View complete list of AILERON THERAPEUTICS INC shareholders